{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:13:43Z","timestamp":1791764023798,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajoc.2024.102224","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T16:57:08Z","timestamp":1732294628000},"page":"102224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Advanced pentosan polysulfate sodium maculopathy with low cumulative exposure and hydroxychloroquine use"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4516-6795","authenticated-orcid":false,"given":"Elena","family":"Flester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaden H.","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamanga","family":"Borooah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2024.102224_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2165\/00003495-200666060-00006","article-title":"Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis","volume":"66","author":"Anderson","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.ajoc.2024.102224_bib2","series-title":"Elmiron (Pentosan Polysulfate Sodium) NDA 020193\/S015 Approval Letter","year":"1996"},{"issue":"11","key":"10.1016\/j.ajoc.2024.102224_bib3","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajoc.2024.102224_bib4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic spectrum of pentosan polysulfate sodium\u2013associated maculopathy: a multicenter study","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102224_bib5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","volume":"127","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"issue":"suppl 4","key":"10.1016\/j.ajoc.2024.102224_bib6","article-title":"MP47-03 Chronic exposure to pentosan polysulfate sodium is associated with retinal pigmentary changes and vision loss","volume":"201","author":"Foote","year":"2019","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.ajoc.2024.102224_bib7","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/IAE.0000000000003078","article-title":"Pentosan polysulfate and vision: findings from an international survey of exposed individuals","volume":"41","author":"Ulner","year":"2021","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102224_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.survophthal.2021.05.005","article-title":"Pentosan polysulfate maculopathy","volume":"67","author":"Lindeke-Myers","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102224_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2021.02.025","article-title":"Pentosan polysulfate maculopathy: prevalence, spectrum of disease, and choroidal imaging analysis based on prospective screening","volume":"227","author":"Wang","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102224_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2024.102224_bib11","first-page":"1174","article-title":"Pentosan polysulfate sodium (Elmiron) maculopathy: a genetic perspective","volume":"43","author":"Kalaw","year":"2023","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102224_bib12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jamaophthalmol.2020.2349","article-title":"Disease course in patients with pentosan polysulfate sodium-associated maculopathy after drug cessation","volume":"138","author":"Shah","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102224_bib13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/rheumatology\/kev357","article-title":"Hydroxychloroquine-related retinal toxicity","volume":"55","author":"Ding","year":"2016","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102224_bib14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/eye.2016.298","article-title":"Hydroxychloroquine retinopathy","volume":"31","author":"Yusuf","year":"2017","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102224_bib15","first-page":"322","article-title":"Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review","volume":"7","author":"Geam\u0103nu Panc\u0103","year":"2014","journal-title":"J Med Life."},{"issue":"6","key":"10.1016\/j.ajoc.2024.102224_bib16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archopht.125.6.775","article-title":"High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy","volume":"125","author":"Rodriguez-Padilla","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102224_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/bjophthalmol-2019-314765","article-title":"Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort","volume":"104","author":"Jain","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102224_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/APO.0000000000000504","article-title":"Age-related macular degeneration masquerade: a review of pentosan polysulfate maculopathy and implications for clinical practice","volume":"11","author":"Mukhopadhyay","year":"2022","journal-title":"Asia Pac J Ophthalmol (Phila)."},{"issue":"1","key":"10.1016\/j.ajoc.2024.102224_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcjo.2021.02.007","article-title":"Pentosan polysulfate maculopathy versus age-related macular degeneration: Comparative assessment with multimodal imaging","volume":"57","author":"Christiansen","year":"2022","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102224_bib20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9394(02)02296-1","article-title":"Optical coherence tomography findings in nicotinic acid maculopathy","volume":"135","author":"Spirn","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102224_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/ICB.0b013e318193492c","article-title":"Cystoid macular edema secondary to paclitaxel (abraxane)","volume":"3","author":"Risard","year":"2009","journal-title":"Retina Cases Brief Rep"},{"key":"10.1016\/j.ajoc.2024.102224_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/JIR.S5706","article-title":"Etiology and treatment of the inflammatory causes of cystoid macular edema","volume":"2","author":"Cho","year":"2009","journal-title":"J Inflamm Res"},{"issue":"Suppl1","key":"10.1016\/j.ajoc.2024.102224_bib23","first-page":"S203","article-title":"Prostaglandins and cystoid macular edema","volume":"47","author":"Miyake","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102224_bib24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archopht.1966.03850010648005","article-title":"Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study","volume":"76","author":"Gass","year":"1966","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102224_bib25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/OPTH.S4033","article-title":"Cystoid macular edema","volume":"2","author":"Rotsos","year":"2008","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102224_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/APO.0000000000000598","article-title":"Update on retinal vein occlusion","volume":"12","author":"Romano","year":"2023","journal-title":"Asia Pac J Ophthalmol (Phila)."},{"key":"10.1016\/j.ajoc.2024.102224_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100797","article-title":"Optical coherence tomography diagnostic signs in posterior uveitis","volume":"75","author":"Pichi","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102224_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102224_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV Standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102224_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10633-015-9504-z","article-title":"Erratum to: ISCEV Standard for full-field clinical electroretinography (2015 update)","volume":"131","author":"McCulloch","year":"2015","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102224_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0161-6420(02)01563-4","article-title":"Indocyanine green angiography in chorioretinal diseases: Indications and interpretation: an evidence-based update","volume":"110","author":"Stanga","year":"2003","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102224_bib32","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","article-title":"Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment","volume":"33","author":"Koh","year":"2013","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102224_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-017-9621-y","article-title":"ISCEV guide to visual electrodiagnostic procedures","volume":"136","author":"Robson","year":"2018","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102224_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10633-017-9580-3","article-title":"ISCEV standard for clinical electro-oculography (2017 update)","volume":"134","author":"Constable","year":"2017","journal-title":"Doc Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102224_bib35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/ICB.0000000000001090","article-title":"Potential new-onset clinically detectable pentosan polysulfate maculopathy years after drug cessation","volume":"16","author":"Barnett","year":"2022","journal-title":"Retin Cases Brief Rep"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102224_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/23258160-20201223-04","article-title":"New insights into pentosan polysulfate maculopathy","volume":"52","author":"Abou-Jaoude","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102224_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.oret.2021.07.004","article-title":"Expanded Clinical Spectrum of pentosan polysulfate maculopathy: a macula society collaborative study","volume":"6","author":"Jain","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102224_bib38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ICB.0000000000001013","article-title":"Pentosan polysulfate sodium-induced pigmentary maculopathy with nonleaking cystoid macular edema successfully treated with anti-vascular endothelial growth factor therapy","volume":"16","author":"De Larochelli\u00e8re","year":"2022","journal-title":"Retin Cases Brief Rep"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102224_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.65.2.28","article-title":"Pentosan polysulfate sodium causes diminished function and subtle morphological changes in retina and RPE of mice","volume":"65","author":"Girardot","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102224_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1167\/iovs.65.4.47","article-title":"Erratum in: pentosan polysulfate sodium causes diminished function and subtle morphological changes in retina and RPE of mice","volume":"65","author":"Girardot","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2024.102224_bib41","doi-asserted-by":"crossref","unstructured":"Wolfe F, Marmor MF. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. 1020;62(6):775-784. doi:10.1002\/acr.20133.","DOI":"10.1002\/acr.20133"},{"key":"10.1016\/j.ajoc.2024.102224_bib42","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2147\/OPTH.S14257","article-title":"Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the \u201cflying saucer\u201d sign)","volume":"4","author":"Chen","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102224_bib43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/cts.12808","article-title":"Systemic lupus erythematosus activity affects the sinusoidal uptake transporter OATP1B1 evaluated by the pharmacokinetics of atorvastatin","volume":"13","author":"Cestari","year":"2020","journal-title":"Clin Transl Sci."},{"issue":"3","key":"10.1016\/j.ajoc.2024.102224_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1517\/17425255.2011.553600","article-title":"The role of cytokines in the regulation of drug disposition:extended functional pleiotropism?","volume":"7","author":"Liptrott","year":"2011","journal-title":"Expert Opin Metab Toxicol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102224_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion","volume":"136","author":"Park","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102224_bib46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","article-title":"Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema","volume":"136","author":"Jonas","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102224_bib47","article-title":"Treatment of cystoid macular oedema secondary to pentosan polysulfate maculopathy using anti-VEGF and intravitreal steroid injections","author":"De Silva","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102224_bib48","series-title":"Ozurdex (Dexamethasone Intravitreal Implant) NDA 022315\/S000 Approval Letter","year":"2009"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102224_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bjophthalmol-2018-312363","article-title":"Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy","volume":"103","author":"Ugwuegbu","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102224_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100060","article-title":"Deep learning-based automatic detection of ellipsoid zone loss in spectral-domain OCT for hydroxychloroquine retinal toxicity screening","volume":"1","author":"De Silva","year":"2021","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ajoc.2024.102224_bib51","article-title":"An unusual case of rapid resolution of bilateral vitelliform deposits after discontinuation of pentosan polysulfate sodium","volume":"32","author":"Kalaw","year":"2023","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"3-4","key":"10.1016\/j.ajoc.2024.102224_bib52","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1093\/milmed\/usab301","article-title":"Macular findings of patients on pentosan polysulfate sodium","volume":"188","author":"Blackorby","year":"2023","journal-title":"Mil Med"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102224_bib53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000485852","article-title":"Repeated dexamethasone intravitreal implant for the treatment of diabetic macular oedema unresponsive to anti-VEGF therapy: outcome and predictive SD-OCT features","volume":"239","author":"Hatz","year":"2018","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102224_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000512195","article-title":"Effect of dexamethasone intravitreal implant on visual acuity and foveal photoreceptor integrity in macular edema secondary to retinal vascular disease","volume":"244","author":"Castro-Navarro","year":"2021","journal-title":"Ophthalmologica"},{"issue":"9","key":"10.1016\/j.ajoc.2024.102224_bib55","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jamaophthalmol.2013.4244","article-title":"Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging","volume":"131","author":"Mititelu","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102224_bib56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/IAE.0000000000002437","article-title":"Longitudinal changes in eyes with hydroxychloroquine retinal toxicity","volume":"39","author":"Allahdina","year":"2019","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102224_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/ICB.0000000000000993","article-title":"Topographic optical coherence tomography segmentation shows limited ellipsoid zone recovery in mild hydroxychloroquine retinopathy","volume":"16","author":"De Sisternes","year":"2022","journal-title":"Retina Cases Brief Rep"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624002342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624002342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:40:00Z","timestamp":1737693600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624002342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"alternative-id":["S2451993624002342"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102224","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced pentosan polysulfate sodium maculopathy with low cumulative exposure and hydroxychloroquine use","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102224"}}